Taken together, these findings suggest that activation of the PERK/EIF2A/ATF/CHOP pathway contributes to AAA development, and inhibition abrogates aneurysm formation by decreasing VSMC apoptosis. This evidence concerns the gene EIF2AK3 and triple-A syndrome.